Mechanisms of intrahepatic triglyceride accumulation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 28, 2016; 22(4): 1664-1673
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664

Table 2 Overview on drug-induced micro- or macrovesicular forms of fatty liver disease (adapted from[108,123])

Causes of drug-induced fatty liver disease
Predominantly microvesicular pattern:
Tetracyclin
Valproic acid
Amiodarone
Glucocorticoids
5-FU
Margosa oil
Predominantly macrovesicular pattern:
Acetylsalicylic acid (intoxication)
Tamoxifen
Mixed pattern:
Antiretroviral agents (e.g., didanosine, stavudine)
Methotrexate

Citation: Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1664.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1664

Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673 [PMID: 26819531 DOI: 10.3748/wjg.v22.i4.1664]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.